These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12183047)

  • 41. Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice.
    Smeyne RJ; Breckenridge CB; Beck M; Jiao Y; Butt MT; Wolf JC; Zadory D; Minnema DJ; Sturgess NC; Travis KZ; Cook AR; Smith LL; Botham PA
    PLoS One; 2016; 11(10):e0164094. PubMed ID: 27788145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease.
    Varastet M; Riche D; Maziere M; Hantraye P
    Neuroscience; 1994 Nov; 63(1):47-56. PubMed ID: 7898660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice.
    Kang JM; Jung JC; Kim H; Lim H; Jang S; Oh S
    Arch Pharm Res; 2008 Sep; 31(9):1098-107. PubMed ID: 18806951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study.
    Yadav SK; Pandey S; Singh B
    J Chem Neuroanat; 2017 Nov; 85():50-59. PubMed ID: 28711564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
    Jiang H; Li LJ; Wang J; Xie JX
    Exp Neurol; 2008 Aug; 212(2):532-7. PubMed ID: 18577498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo.
    Luo FC; Wang SD; Qi L; Song JY; Lv T; Bai J
    J Ethnopharmacol; 2011 Jan; 133(2):448-53. PubMed ID: 20951784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
    Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
    J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Carta AR; Kachroo A; Schintu N; Xu K; Schwarzschild MA; Wardas J; Morelli M
    J Neurochem; 2009 Dec; 111(6):1478-89. PubMed ID: 19817968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice.
    Blanchet J; Longpré F; Bureau G; Morissette M; DiPaolo T; Bronchti G; Martinoli MG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1243-50. PubMed ID: 18471948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
    J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sparing of orexin-A and orexin-B neurons in the hypothalamus and of orexin fibers in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated macaques.
    Bensaid M; Tandé D; Fabre V; Michel PP; Hirsch EC; François C
    Eur J Neurosci; 2015 Jan; 41(1):129-36. PubMed ID: 25328140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine neuron loss by selective deletion of autophagy-related gene 5 is not exacerbated by MPTP toxicity in midbrain.
    Ren YH; Niu XY; Huang HJ; Hao XD; Wang PX; Chi YL; Ding YQ; Liao M
    Neurosci Lett; 2018 May; 675():140-144. PubMed ID: 29175031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gangliosides prevent MPTP toxicity in mice--an immunocytochemical study.
    Gupta M; Schwarz J; Chen XL; Roisen FJ
    Brain Res; 1990 Sep; 527(2):330-4. PubMed ID: 1979240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Regulatory Mechanism and Toxicology of Neurodegenerative Processes in MPTP/Probenecid-Induced Progressive Parkinson's Disease Mice Model Revealed by Transcriptome.
    Yang W; Hao W; Meng Z; Ding S; Li X; Zhang T; Huang W; Xu L; Zhang Y; Yang J; Gu X
    Mol Neurobiol; 2021 Feb; 58(2):603-616. PubMed ID: 32997292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ginsenoside Rg1 modulates COX-2 expression in the substantia nigra of mice with MPTP-induced Parkinson disease through the P38 signaling pathway].
    Wang Q; Zheng H; Zhang ZF; Zhang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1594-8. PubMed ID: 18819875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.